Linden Thomas Advisory Services, LLC Halozyme Therapeutics, Inc. Transaction History
Linden Thomas Advisory Services, LLC
- $908 Billion
- Q2 2025
A detailed history of Linden Thomas Advisory Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 35,235 shares of HALO stock, worth $2.28 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
35,235
Previous 35,881
1.8%
Holding current value
$2.28 Million
Previous $2.29 Billion
19.94%
% of portfolio
0.2%
Previous 0.3%
Shares
11 transactions
Others Institutions Holding HALO
# of Institutions
629Shares Held
127MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$791 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$384 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$224 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$220 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...